Biogen Inc.BIIBNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank15
Year-over-Year Change
Year-over-year free cash flow growth rate
Latest
-54.67%
↓ 190% vs avg
Percentile
P15
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
60.81%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -54.67% |
| Q3 2025 | 749.83% |
| Q2 2025 | -32.00% |
| Q1 2025 | -69.45% |
| Q4 2024 | -13.78% |
| Q3 2024 | 38.13% |
| Q2 2024 | 34.91% |
| Q1 2024 | 920.30% |
| Q4 2023 | -110.44% |
| Q3 2023 | 26.20% |
| Q2 2023 | 2.91% |
| Q1 2023 | 248.13% |
| Q4 2022 | -143.60% |
| Q3 2022 | -13.73% |
| Q2 2022 | 571.51% |
| Q1 2022 | -86.50% |
| Q4 2021 | 3.55% |
| Q3 2021 | -35.66% |
| Q2 2021 | 70.82% |
| Q1 2021 | 244.50% |
| Q4 2020 | -142.67% |
| Q3 2020 | -40.49% |
| Q2 2020 | 39.91% |
| Q1 2020 | -28.77% |
| Q4 2019 | 15.27% |
| Q3 2019 | -9.70% |
| Q2 2019 | 33.38% |
| Q1 2019 | -20.19% |
| Q4 2018 | 8.04% |
| Q3 2018 | 85.16% |
| Q2 2018 | -33.37% |
| Q1 2018 | 2.43% |
| Q4 2017 | -9.37% |
| Q3 2017 | 59.39% |
| Q2 2017 | 201.98% |
| Q1 2017 | -159.57% |
| Q4 2016 | 97.38% |
| Q3 2016 | -17.82% |
| Q2 2016 | 2.69% |
| Q1 2016 | -2.08% |